Medtronic plc (MDT) (Q4FY23) Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio...
This report is useful for M&A and business & investment analysis to all students, researchers, investors, private equity houses, broking firms, hedge funds, advisory...
This report is useful for M&A and business & investment analysis to all students, researchers, investors, private equity houses, broking firms, hedge funds, advisory...
This report is useful for M&A and business & investment analysis to all students, researchers, investors, private equity houses, broking firms, hedge funds, advisory...
MDT continue to advance new technologies that are in development with increased investments in R&D. We expect these investments to create new markets, disrupt...
The Ambulatory Care segment delivered net operating revenues of $738mn in Q1FY22, which climbed 14.24% Y/Y. The improvement can be attributed to new service...
BAX is facing challenges related to increasing costs. The cost structure has been negatively impacted by rising rates of inflation as well as an...
ABT adopts the strategy of innovation to improve its product portfolio which can contribute towards the long term growth. In FY21, ABT continued to...
Encompass Health continue to invest in capacity expansions and opened 8 de novo IRFs and added 117 beds to existing hospitals, increasing licensed bed...
During Q1FY22, the company progressed their innovation pipeline, launching several new products. Examples include BD COR, where it launched molecular MX module, which fully...
Boutique equity research firm providing Business, Investment and M&A research services focused on fast growing Technology, Healthcare, Life science and Industrial sectors.